Aspergillus Previously amphotericin B was considered the first line treatment for aspergillus, however due to its side effect profile alternative agents have been sought. Recent data suggest that for the prevention of invasive fungal infections in at risk patients, voriconazole (a triazole) may be as efficacious (although it should be noted that in the Walsh […]